The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial.

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial.

Pokaži ostale verzije (1)

In the randomized, placebo-controlled, physician-blinded Canadian cooperative trial of cyclophosphamide and plasma exchange, neither active treatment regimens (group I: i.v. cyclophosphamide and prednisone; group II: weekly plasma exchange, oral cyclophosphamide, and prednisone) were superior to pla...

Bibliografski detalji
Glavni autori:	Noseworthy, J, Ebers, G, Vandervoort, M, Farquhar, R, Yetisir, E, Roberts, R
Format:	Journal article
Jezik:	English
Izdano:	1994

Slični predmeti

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article]
od: Noseworthy, J, i dr.
Izdano: (2001)

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial
od: Nosworthy, J, i dr.
Izdano: (2001)

ACCEPTANCE OF PLACEBO-CONTROL TRIAL DESIGN BY PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS
od: Noseworthy, J, i dr.
Izdano: (1989)

Acceptance of placebo-control trial design by progressive multiple sclerosis patients. The Canadian Cooperative Multiple Sclerosis Study Group.
od: Noseworthy, J, i dr.
Izdano: (1989)

A referendum on clinical trial research in multiple sclerosis: the opinion of the participants at the Jekyll Island workshop.
od: Noseworthy, J, i dr.
Izdano: (1989)

INTERRATER VARIABILITY WITH THE EXPANDED DISABILITY STATUS SCALE (EDSS) AND FUNCTIONAL-SYSTEMS (FS) IN A MULTIPLE-SCLEROSIS CLINICAL-TRIAL
od: Noseworthy, J, i dr.
Izdano: (1990)

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.
od: Noseworthy, J, i dr.
Izdano: (1990)

A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.
od: Collins, R, i dr.
Izdano: (1978)

Therapeutic trials in multiple sclerosis.
od: Noseworthy, J, i dr.
Izdano: (1984)

Inter-rater variability on multiple sclerosis disability scales in a blinded, prospective clinical trial
od: Noseworthy, J, i dr.
Izdano: (1989)

ACTIVE RELAPSING AND PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS HAVE SIMILAR MAGNETIC-RESONANCE-IMAGING BEHAVIOR - IMPLICATIONS FOR CLINICAL-TRIAL DESIGN
od: Noseworthy, J, i dr.
Izdano: (1990)

FAILURE TO FIND PATIENTS WITH NERVOUS-SYSTEM MANIFESTATIONS OF PRIMARY SJOGRENS SYNDROME IN A MULTIPLE-SCLEROSIS CLINIC POPULATION
od: Noseworthy, J, i dr.
Izdano: (1988)

SJOGRENS-SYNDROME MIMICKING MULTIPLE-SCLEROSIS - REPLY
od: Noseworthy, J, i dr.
Izdano: (1990)

Primary biliary cirrhosis and multiple sclerosis.
od: Noseworthy, J, i dr.
Izdano: (1989)

Neuroimaging in multiple sclerosis.
od: Noseworthy, J, i dr.
Izdano: (1984)

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis.
od: Weinshenker, BG, i dr.
Izdano: (1992)

The prevalence of primary Sjogren's syndrome in a multiple sclerosis population.
od: Noseworthy, J, i dr.
Izdano: (1989)

Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis
od: Jessica Mandrioli, i dr.
Izdano: (2023-08-01)

MARKERS AND PROGNOSIS IN MULTIPLE-SCLEROSIS
od: Noseworthy, J, i dr.
Izdano: (1983)

Hyperbaric oxygen therapy in chronic stable multiple sclerosis: double-blind study.
od: Harpur, G, i dr.
Izdano: (1986)

Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)
od: Marcus J. Drake, i dr.
Izdano: (2018-08-01)

TIZANIDINE VERSUS BACLOFEN IN THE TREATMENT OF SPASTICITY IN PATIENTS WITH MULTIPLE-SCLEROSIS - A DOUBLE-BLIND-STUDY
od: Bass, B, i dr.
Izdano: (1987)

Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis.
od: Wiebe, S, i dr.
Izdano: (1992)

MRI as an outcome in multiple sclerosis clinical trials.
od: Daumer, M, i dr.
Izdano: (2009)

Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
od: Mehran Rahimlou, i dr.
Izdano: (2022-09-01)

Oligoclonal bands in multiple sclerosis: clinical-pathologic correlation.
od: Farrell, M, i dr.
Izdano: (1985)

Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993 [classical article].
od: IFNB Multiple Sclerosis Study Group
Izdano: (2001)

Disease Modification in Multiple Sclerosis by Flupirtine—Results of a Randomized Placebo Controlled Phase II Trial
od: Jan Dörr, i dr.
Izdano: (2018-10-01)

MRI ASANOUTCOMEIN MULTIPLE SCLEROSIS CLINICAL TRIALS Reply
od: Ebers, G, i dr.
Izdano: (2009)

The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials.
od: Weinshenker, BG, i dr.
Izdano: (1991)

Corrigendum: Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
od: Mehran Rahimlou, i dr.
Izdano: (2022-11-01)

MULTIPLE-SCLEROSIS (MS) PRESENTING IN PATIENTS OVER 50 YEARS OF AGE
od: Noseworthy, J, i dr.
Izdano: (1981)

The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
od: Noseworthy, J
Izdano: (1991)

Plasma exchange for MS.
od: Noseworthy, J, i dr.
Izdano: (1990)

PLASMA-EXCHANGE FOR MS
od: Noseworthy, J, i dr.
Izdano: (1990)

Erratum: Plasma exchange for MS (Neurology (1990) 40 (864-866))
od: Noseworthy, J, i dr.
Izdano: (1990)

Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial
od: Ethel Ciampi, i dr.
Izdano: (2020-05-01)

Effect of Vitamin A Supplementation on Fatigue and Depression in Multiple Sclerosis Patients: A Double-blind Placebo-controlled Clinical Trial
od: Sama Bitarafan, i dr.
Izdano: (2016-01-01)

Treatment of acute respiratory infection in adults: results of a multicenter randomized double-blind placebo-controlled clinical trial
od: M. P. Kostinov, i dr.
Izdano: (2021-06-01)

IDENTIFYING SUITABLE CANDIDATES FOR CLINICAL-TRIALS OF PROGRESSIVE MULTIPLE-SCLEROSIS
od: Weinshenker, B, i dr.
Izdano: (1993)